Construction and immunogenicity testing of whole recombinant yeast-based T-cell vaccines

Methods in Molecular Biology

Volumn 1404, Issue , 2016, Pages 529-545

  King, Thomas H ^a   Guo, Zhimin ^a   Hermreck, Melanie ^a   Bellgrau, Donald ^a   Rodell, Timothy C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS VACCINE; GAMMA INTERFERON; RECOMBINANT ANTIGEN; RECOMBINANT VACCINE; TARMOGEN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LYSATE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; EXPRESSION VECTOR; FLOW CYTOMETRY; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTECTION; SACCHAROMYCES CEREVISIAE; SHUTTLE VECTOR; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; YEAST CELL; ANIMAL; CYTOLOGY; GENETICS; IMMUNOLOGY;

ANIMALS; FLOW CYTOMETRY; IMMUNIZATION; MICE; SACCHAROMYCES CEREVISIAE; SPLEEN; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 84963805310     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3389-1_35     Document Type: Chapter

References (17)

1. Stubbs A, Martin KS, Coeshott C et al (2001) Whole recombinant yeast vaccine activates dendritic cells and elicits protective cellmediated immunity. Nat Med 7:625–629
2. Cereda V, Vergati M, Huen N-Y et al (2011) Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors to regulatory T cells. Vaccine 29:4992–4999
3. Cheng S-C, van de Veerdonk FL, Lenardon M et al (2011) The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans. J Leukoc Biol 90:357–366
4. Gaggar A, Coeshott C, Apelian D et al (2014) Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study. Vaccine 32:4925–4931
5. Wansley EK, Chakraborty M, Hance KW et al (2008) Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res 14:4316–4325
6. Ardiani A, Farsaci B, Rogers CJ et al (2013) Combination therapy with a second- generation androgen receptor antagonist and a metastasis vaccine improves survival in a spontaneous prostate cancer model. Clin Cancer Res 19:6205–6218
7. Ardiani A, Gameiro SR, Palena C et al (2014) Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process. Cancer Res 74:1945–1957
8. King TH, Kemmler CB, Guo Z et al (2014) A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. PLoS One 9(7):e101904
9. Haller A, Lauer GM, King TH et al (2007) Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins. Vaccine 25:1452–1463
10. Wu H, Ng BSH, Thibault G (2014) Endoplasmic reticulum stress response in yeast and humans. Biosci Rep 34:321–330
11. Shen MWY, Fang F, Sandmeyer S et al (2012) Development and characterization of a vector set with regulated promoters for systematic metabolic engineering in Saccharomyces cerevisiae. Yeast 29:495–503
12. Nakagawa S, Niimura Y, Gojobori T et al (2008) Diversity of preferred nucleotide sequences around the translation initiation codon in eukaryote genomes. Nucleic Acids Res 36:861–871
13. Schaffner W, Weissmann C (1973) A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem 56:502–514
14. Hamilton DH, Litzinger MT, Jales A et al (2013) Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine. Oncotarget 4:1777–1790
15. Betts MR, Brenchley JM, Price DA et al (2003) Sensitive and viable identification of antigenspecific CD8 + T cells by a flow cytometric assay for degranulation. J Immunol Methods 281:65–78
16. Andersson HA, Barry MA (2004) Maximizing antigen targeting to the proteasome for genebased vaccines. Mol Ther 10:432–446
17. Liard C, Munier S, Joulin-Giet A et al (2011) Intradermal immunization triggers epidermal Langerhans cell mobilization required for CD8 T-cell immune responses. J Invest Dermatol 132:615–625